Skip to main content

Table 3 Drug treatment registered at baseline (before change) by class

From: The management of bipolar mania: a national survey of baseline data from the EMBLEM study in Italy

Monotherapy (n = 186)

Co-therapy with 2 drugs (n = 150)

Polytherapy (> 2 drugs) (n = 135)

Drug

N (%)

Drugs

N (%)

Drugs

N (%)

Haloperidol

45 (24.2)

Other typical/atypical

15 (10.0)

Haloperidol/other typicals/other AC

11 (8.2)

Valproate

31 (16.7)

Haloperidol/Lithium

12 (8.0)

Haloperidol/other typicals/Valproate

11 (8.2)

Lithium

27 (14.5)

Olanzapine/Valproate

10 (6.7)

Haloperidol/other typicals/Lithium

8 (5.9)

Olanzapine

19 (10.2)

Risperidone/non-valproate AC

10 (6.7)

Other typicals/other AC/Lithium

8 (5.9)

Other typical

18 (9.7)

Other typical/Valproate

10 (6.7)

Haloperidol/other typicals

3 (2.2)

Risperidone

16 (8.6)

Risperidone/Lithium

9 (6.0)

Other typicals/Valproate/Lithium

2 (1.5)

Other AC

14 (7.6)

2 typicals

9 (6.0)

Other combinations

92 (68.1)

Quetiapine

10 (5.4)

Other typical/Lithium

8 (5.3)

  

Other atypical

6 (3.2)

Haloperidol/Valproate

8 (5.3)

  
  

Lithium/non-valproate AC

8 (5.3)

  
  

Olanzapine/Lithium

7 (4.7)

  
  

Haloperidol/non-valproate AC

7 (4.7)

  
  

Other combinations

37 (24.7)

  
  1. AC = Anticonvulsivants;